Global pediatric interventional cardiology market was valued US$ 1.4 Bn in 2017 and is expected to reach US$ 2.72 Bn by 2026, at a CAGR of 8.66 % during a forecast period.
Global Pediatric Interventional Cardiology Market
Pediatric is the branch of medicine that includes the medical care of infants, children, and adolescents.
The constant progress of novel minimally invasive devices and the growing populace base of pediatric patients are boosting the growth of the market during the forecast period. The rising occurrences of congenital heart conditions between pediatric patients, initiatives taken by regulatory authorities to reinforce the interventional cardiology segment and rising expenses by market applicants for the R&D of novel heart controller products is also propelling the growth of the global pediatric interventional cardiology market. However, Complex regulatory procedures are limiting the growth of the market.
Closure devices are used to close a fault between the right and left sides of the heart. Some of these birth defects are located in the wall such as septum between the upper chambers that is atria of the heart.
Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure to exchange a narrowed aortic valve that fails to open properly aortic valve stenosis. In TAVR procedure, doctors insert a catheter in a patient’s leg or chest and guide it to your heart. Transcatheter aortic valve replacement carries some risk factors, which may include bleeding, blood vessel complications, stroke, kidney disease, and heart attack. TAVR improves the lives of people with aortic stenosis for whom surgery is too risky and TAVR can reduce the risk of death.
Europe is estimated for the largest share of the pediatric interventional cardiology market owing to a large number of approved interventional cardiology devices present in the European market as well as funds by venture capitalists, and collaborations between key players in the market. Asia-Pacific region has significant growth opportunities owing to the high growth is the improving healthcare infrastructure in this region. Moreover, the development in government investments for improving pediatric care facilities is driving the growth of this region.
Key player operating in the global pediatric interventional cardiology market are Danaher, Abbott Laboratories, Siemens AG, GENERAL ELECTRIC, Toshiba Corporation, Boston Scientific Corporation, W.L. Gore & Associates, Inc., Johnson & Johnson Services, Inc., BIOTRONIK, Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd., Medtronic, NuMED, Inc., Cook, PEDIAVASCULAR, Edwards Lifesciences Corporatio, Agilent Technologies, Pfm Medical Ag, and Scranton Gillette Communication.
The report covers a comprehensive study of major market drivers, restrains, opportunities, challenges, PESTEL, Porters, SWOT, and technological forecasting in the market.
The Scope of Global Pediatric Interventional Cardiology Market:
Global Pediatric Interventional Cardiology Market, by Device Type:
• Congenital Heart Defect Closure Devices
• Transcatheter Heart Valves
• Other Device Type
Global Pediatric Interventional Cardiology Market, by End Users:
• Home Healthcare
• Other End Users
Global Pediatric Interventional Cardiology Market, by Region:
• North America
• South America
• Middle East & Africa
Key Player Operating In the Global Pediatric Interventional Cardiology Market:
• Abbott Laboratories
• Siemens AG
• GENERAL ELECTRIC
• Toshiba Corporation
• Boston Scientific Corporation
• W.L. Gore & Associates, Inc.
• Johnson & Johnson Services, Inc.
• Koninklijke Philips N.V.
• F. Hoffmann-La Roche Ltd.
• NuMED, Inc.
• Edwards Lifesciences Corporation
• Agilent Technologies
• Pfm Medical Ag
• Scranton Gillette Communication